Qilian International Holding Group Limited (BGM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Qilian International Holding Group Limited (BGM) has a cash flow conversion efficiency ratio of -0.017x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.06 Million) by net assets ($183.49 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See BGM cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Qilian International Holding Group Limited - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Qilian International Holding Group Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Qilian International Holding Group Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Qilian International Holding Group Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Apollo Power Ltd
TA:APLP
|
-0.074x |
|
DrayTek Corp
TW:6216
|
0.002x |
|
Welspun Investments and Commercials Limited
NSE:WELINV
|
-0.002x |
|
Hunya Foods Co Ltd
TW:1236
|
0.036x |
|
Inoue Rubber (Thailand) Public Company Limited
BK:IRC
|
0.010x |
|
EMEK Elektrik Endustrisi AS
IS:EMKEL
|
-0.006x |
|
Ferrum S.A.
BA:FERR
|
-0.007x |
|
Scana ASA
OL:SCANA
|
0.064x |
Annual Cash Flow Conversion Efficiency for Qilian International Holding Group Limited (2017–2024)
The table below shows the annual cash flow conversion efficiency of Qilian International Holding Group Limited from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see Qilian International Holding Group Limit (BGM) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-09-30 | $44.09 Million | $544.24K | 0.012x | +75.34% |
| 2023-09-30 | $44.35 Million | $312.21K | 0.007x | -96.94% |
| 2022-09-30 | $54.96 Million | $12.65 Million | 0.230x | +3681.28% |
| 2021-09-30 | $56.67 Million | $345.03K | 0.006x | -96.54% |
| 2020-09-30 | $28.84 Million | $5.08 Million | 0.176x | +786.70% |
| 2019-09-30 | $22.64 Million | $-580.20K | -0.026x | -110.23% |
| 2018-09-30 | $17.72 Million | $4.44 Million | 0.250x | +27.54% |
| 2017-09-30 | $13.66 Million | $2.68 Million | 0.196x | -- |
About Qilian International Holding Group Limited
BGM Group Ltd., through its subsidiaries, operates as a pharmaceutical and chemical company in China. It offers oxytetracycline products, including Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline active pharmaceutical ingredients, which are used by pharmaceutical companies in the manufactu… Read more